联系客服

603939 沪市 益丰药房


首页 公告 益丰药房:益丰药房关于2023年第三季度主要经营数据的公告

益丰药房:益丰药房关于2023年第三季度主要经营数据的公告

公告日期:2023-10-31

益丰药房:益丰药房关于2023年第三季度主要经营数据的公告 PDF查看PDF原文

 证券代码:603939        证券简称:益丰药房        公告编号:2023-095
          益丰大药房连锁股份有限公司

    关于2023年第三季度主要经营数据的公告

    本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。

    根据上海证券交易所发布的上市公司分行业信息披露指引及《关于做好主 板上市公司 2023 年第三季度报告披露工作的主要提醒》相关要求,现将益丰 大药房连锁股份有限公司(以下简称“公司”)2023 年第三季度主要经营数据披 露如下:

    一、报告期末主要经营数据

    1、主要会计数据及财务指标

                                                      单位:元 币种:人民币

                                      本报告期                    年初至报告
项目                    本报告期      比上年同    年初至报告期末  期末比上年
                                      期增减变                    同期增减变
                                      动幅度(%)                    动幅度(%)

营业收入            5,181,484,438.58      12.70  15,888,047,446.63        19.03

归属于上市公司股东

的净利润              294,030,212.68      18.96    999,183,766.34        21.32

归属于上市公司股东

的扣除非经常性损益    287,360,171.58      22.13    966,128,138.49        21.58
的净利润

经营活动产生的现金          不适用    不适用

流量净额                                          2,881,891,859.25        24.86

基本每股收益(元/股)            0.29      20.83              0.99        20.73

稀释每股收益(元/股)            0.29      20.83              0.99        22.22

加权平均净资产收益                                                增加 0.61 个
率(%)                        3.48        0.14            11.17      百分点

                                                                    本报告期末
                      本报告期末              上年度末            比上年度末
                                                                    增减变动幅

                                                                      度(%)

总资产              21,935,278,533.96              21,038,886,640.04        4.26

归属于上市公司股东

的所有者权益        9,389,512,616.60              8,556,078,527.92        9.74

    2、主营业务分行业、分产品、分地区情况

                              主营业务分行业情况

                                                      营业收  营业成  毛利率比
                                            毛利率  入比上  本比上  上年同期
 分行业      营业收入        营业成本      (%)  年同期  年同期    增减
                                                      增减    增减    (%)
                                                      (%)  (%)

 零售    14,211,402,385.80  8,452,240,947.88    40.52    17.52      19.40  减少 0.94
                                                                        个百分点

 批发      1,258,881,504.14  1,135,426,650.97    9.81    44.14      43.28  增加 0.54
                                                                        个百分点

 合计    15,470,283,889.94  9,587,667,598.85    38.03    19.32    21.81  减少 1.27
                                                                        个百分点

                              主营业务分产品情况

                                                      营业收  营业成  毛利率比
                                            毛利率  入比上  本比上  上年同期
 分产品      营业收入        营业成本      (%)  年同期  年同期    增减
                                                      增减    增减    (%)
                                                      (%)  (%)

中西成药  11,998,030,762.55  7,809,564,588.61    34.91    20.84    22.03  减少 0.64
                                                                        个百分点

 中药      1,515,192,015.03    775,366,066.05    48.83    28.34    27.39  增加 0.38
                                                                        个百分点

 非药品    1,957,061,112.36  1,002,736,944.19    48.76    5.44    16.22  减少 4.75
                                                                        个百分点

 合计    15,470,283,889.94  9,587,667,598.85    38.03    19.32    21.81  减少 1.27
                                                                        个百分点

                              主营业务分地区情况

    分地区                    营业收入              营业收入比上年同期增减(%)

      中南                          7,210,715,512.04                        21.52

      华东                          6,421,435,671.16                        11.24

      华北                          1,838,132,706.74                        45.94

      合计                          15,470,283,889.94                        19.32

    说明:中南地区包括:湖南省、湖北省、广东省;华东地区包括:江苏省、上海市、 浙江省、江西省;华北地区包括:河北省、北京市、天津市 (下同)。

    二、报告期门店变动情况

    1、门店扩张情况

    2023 年 1-9 月,公司新增门店 2,240 家,其中,自建门店 1,046 家,并购
 门店 368 家,新增加盟店 826 家,另,迁址门店 49 家,关闭门店 109 家,至
 报告期末,公司门店总数 12,350 家(含加盟店 2,788 家)。

                                        2023 年 1-9 月

    地区

              期初(家)    新增(家)  关闭(家)  迁址(家)  期末(家)

  中南地区      5,414        1,066        55          25          6,400

  华东地区      3,795          729        45          22          4,457

  华北地区      1,059          445          9          2          1,493

    合计        10,268        2,240        109        49        12,350

    2、门店取得医保资质情况

    截至 2023 年 9 月 30 日,公司 9,562 家直营连锁门店,已取得各类“医疗保
 险定点零售药店”资格的药店 8,327 家,占公司直营门店总数比例为 87.08%。

序号      地区      门店数量(家)  获得各类医保定点资格  占药店总数的比例
                                        门店
[点击查看PDF原文]